CR6888A - Sales estables de acido o-acetilsalicilico con aminoacidos basicos - Google Patents

Sales estables de acido o-acetilsalicilico con aminoacidos basicos

Info

Publication number
CR6888A
CR6888A CR6888A CR6888A CR6888A CR 6888 A CR6888 A CR 6888A CR 6888 A CR6888 A CR 6888A CR 6888 A CR6888 A CR 6888A CR 6888 A CR6888 A CR 6888A
Authority
CR
Costa Rica
Prior art keywords
amino acids
basic amino
stable
acid salts
acetilsalicilic
Prior art date
Application number
CR6888A
Other languages
English (en)
Inventor
Franckowiak Gerhard
Appolt Hubert
Leifker Gregor
Peter Wirges Hans
Ledwoch Wolfram
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of CR6888A publication Critical patent/CR6888A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Se refiere a sales estables de acido o-acetilsaliciclico con aminoacidos basicos, a un procedimiento para su preparacion asi como a su uso como medicamento.
CR6888A 2000-07-18 2003-01-17 Sales estables de acido o-acetilsalicilico con aminoacidos basicos CR6888A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10034802A DE10034802A1 (de) 2000-07-18 2000-07-18 Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren

Publications (1)

Publication Number Publication Date
CR6888A true CR6888A (es) 2004-10-28

Family

ID=7649258

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6888A CR6888A (es) 2000-07-18 2003-01-17 Sales estables de acido o-acetilsalicilico con aminoacidos basicos

Country Status (33)

Country Link
US (2) US6773724B2 (es)
EP (1) EP1365737B1 (es)
JP (2) JP2004507463A (es)
KR (1) KR100773658B1 (es)
CN (1) CN1205176C (es)
AR (1) AR030305A1 (es)
AT (1) ATE293589T1 (es)
AU (2) AU2001278471B2 (es)
BR (1) BR0112538A (es)
CA (1) CA2416288C (es)
CR (1) CR6888A (es)
CZ (1) CZ300337B6 (es)
DE (2) DE10034802A1 (es)
DK (1) DK1365737T3 (es)
EC (1) ECSP034437A (es)
ES (1) ES2241849T3 (es)
GT (1) GT200100134A (es)
HR (1) HRP20030108B1 (es)
HU (1) HUP0302053A3 (es)
IL (2) IL153873A0 (es)
MX (1) MXPA03000510A (es)
MY (1) MY134521A (es)
NO (1) NO20030222D0 (es)
PE (1) PE20020267A1 (es)
PL (1) PL204593B1 (es)
PT (1) PT1365737E (es)
RS (1) RS50329B (es)
SK (1) SK286162B6 (es)
SV (1) SV2002000557A (es)
TW (1) TWI299729B (es)
UY (1) UY26841A1 (es)
WO (1) WO2002005782A2 (es)
ZA (1) ZA200300469B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
US8142810B2 (en) 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
ATE442352T1 (de) * 2003-05-16 2009-09-15 Cephalon France Verfahren zur herstellung von modafinil
WO2006023844A2 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
DE102005025283A1 (de) 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
DE102005049293A1 (de) * 2005-10-15 2007-04-26 Bayer Healthcare Ag Kombinationspräparate von Salzen oder o-Acetylsalicylsäure
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
AU2006346195B2 (en) 2006-07-09 2013-03-07 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
KR20210103586A (ko) 2007-06-04 2021-08-23 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도
DE102008004386A1 (de) 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
CN101314029B (zh) * 2008-06-18 2010-12-08 四川省农业科学院实验场 乙酰水杨酸肽及其制备方法
US20100120727A1 (en) * 2008-11-12 2010-05-13 Kyphia Pharmaceuticals, Inc. Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
RU2630577C2 (ru) 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
US8889902B2 (en) * 2009-06-25 2014-11-18 Tetra, Sia Acetylsalicylic acid salts
CN101633624B (zh) * 2009-08-04 2013-05-01 蚌埠丰原医药科技发展有限公司 改进的赖氨匹林的制备方法
FR2950625B1 (fr) * 2009-09-30 2016-12-02 Holis Tech Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
FR2965261B1 (fr) * 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
FR2973370B1 (fr) * 2011-03-29 2013-05-03 Holis Technologies Procede a faible cout pour la preparation d'un acide o-acetylsalicyclique et d'un acide amine basique
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
CN116898848A (zh) 2012-01-18 2023-10-20 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物
CN102976962B (zh) * 2012-11-20 2015-02-04 南京工业大学 L-鸟氨酸阿司匹林复盐及其制备方法和应用
FR3021654B1 (fr) * 2014-05-28 2016-06-24 Unither Pharmaceuticals Procede de preparation d'un sel d'acide acetylsalicylique et d'un acide amine basique
EP3558920B1 (en) * 2016-12-23 2021-04-07 AspiAir GmbH Improved synthesis of lysine acetylsalicylate · glycine particles
US11096949B2 (en) 2017-05-30 2021-08-24 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid
KR20200035047A (ko) * 2017-08-03 2020-04-01 산텐 세이야꾸 가부시키가이샤 클로르헥시딘을 함유하는 의약 조성물
CN113105326A (zh) * 2021-03-24 2021-07-13 海南卓华制药有限公司 赖氨匹林的制备方法及应用
CN114478287A (zh) * 2021-12-31 2022-05-13 蚌埠丰原医药科技发展有限公司 一种赖氨匹林晶型及制备方法和应用
AU2023205426A1 (en) 2022-01-05 2024-06-13 Aspiair Gmbh Improved synthesis of lysine acetylsalicylate · glycine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
ES388158A1 (es) * 1971-02-11 1974-03-16 Liade Sa Lab Procedimiento de obtencion de sales solubles del acido ace-til salicilico.
JPS4856815A (es) * 1971-11-13 1973-08-09
JPS55127345A (en) * 1979-03-23 1980-10-02 Kyowa Hakko Kogyo Co Ltd Preparation of acetylsalicylic acid salt
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS56113741A (en) * 1980-02-13 1981-09-07 Mitsui Toatsu Chem Inc Preparation of crystal of acetylsalicylic acid salt
JPS5721345A (en) * 1980-07-15 1982-02-04 Mitsui Toatsu Chem Inc Purification of acetylsalicylate salt
CS247688B1 (cs) * 1984-12-22 1987-01-15 Evzen Kasafirek Způsob výroby soli lysinu s kyselinou acetylsalicylovou
JPS632929A (ja) * 1986-06-20 1988-01-07 Kao Corp アセチルサリチル酸製剤
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
HUP0302053A3 (en) 2010-03-29
AU2001278471B2 (en) 2004-07-22
PE20020267A1 (es) 2002-06-08
US7449198B2 (en) 2008-11-11
NO20030222L (no) 2003-01-16
EP1365737A2 (de) 2003-12-03
AU7847101A (en) 2002-01-30
DK1365737T3 (da) 2005-07-11
SV2002000557A (es) 2002-10-24
BR0112538A (pt) 2003-09-09
GT200100134A (es) 2002-03-22
MXPA03000510A (es) 2004-04-20
KR100773658B1 (ko) 2007-11-05
KR20030019586A (ko) 2003-03-06
RS50329B (sr) 2009-09-08
WO2002005782A2 (de) 2002-01-24
HRP20030108B1 (en) 2006-12-31
PL365648A1 (en) 2005-01-10
CA2416288C (en) 2009-12-22
CN1205176C (zh) 2005-06-08
CN1468209A (zh) 2004-01-14
DE10034802A1 (de) 2002-01-31
AR030305A1 (es) 2003-08-20
US20020091108A1 (en) 2002-07-11
UY26841A1 (es) 2002-02-28
CZ2003164A3 (cs) 2003-04-16
TWI299729B (en) 2008-08-11
NO20030222D0 (no) 2003-01-16
PT1365737E (pt) 2005-08-31
ES2241849T3 (es) 2005-11-01
EP1365737B1 (de) 2005-04-20
US6773724B2 (en) 2004-08-10
MY134521A (en) 2007-12-31
ZA200300469B (en) 2004-06-21
DE50105985D1 (de) 2005-05-25
CZ300337B6 (cs) 2009-04-22
US20050009791A1 (en) 2005-01-13
SK672003A3 (en) 2003-06-03
IL153873A (en) 2009-05-04
HUP0302053A2 (hu) 2003-09-29
JP2004507463A (ja) 2004-03-11
WO2002005782A3 (de) 2003-10-02
IL153873A0 (en) 2003-07-31
YU2003A (sh) 2006-08-17
ATE293589T1 (de) 2005-05-15
PL204593B1 (pl) 2010-01-29
SK286162B6 (sk) 2008-04-07
HK1061811A1 (en) 2004-10-08
ECSP034437A (es) 2003-03-31
JP2012131824A (ja) 2012-07-12
HRP20030108A2 (en) 2005-02-28
CA2416288A1 (en) 2003-01-15

Similar Documents

Publication Publication Date Title
CR6888A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos
CR9556A (es) Complejo ingrediente activo estable de sales del acido-o-acetilsalicilico con aminoacidos basicos y glicina
CR6895A (es) Nuevos compuestos heterociclicos su preparacion y su utilizacion como medicamentos en especial como antibacterianos
BRPI0112584B8 (pt) ésteres oxigenados de derivados de ácido benzidroxâmico de 4-iodofenilamino, composição farmacêutica e combinação
CR11008A (es) Sales, composiciones liquidas acuosas que contienen sales de acido s-(+)- abscisico y metodos para su preparacion
PE120599A1 (es) Procedimiento para preparar compuestos quirales
BRPI0508704A (pt) métodos para a preparação de um composto e para a preparação de calcipotriol ou monoidrato de calcipotriol, composto, e, usos de um composto e de éster dietìlico do ácido (2-ciclopropil-2-oxoetil) fosfÈnico
NO20030182D0 (no) Dermalt påföringssystem for aminolevulinsyre
HN2000000045A (es) Nuevas combinaciones farmaceuticas para inhibidores de la nos.
ECSP045192A (es) "SALES ESTABLES DEL ACIDO o-ACETILSALICILICO CON AMINOÁCIDOS BÁSICOS II"
PT1289930E (pt) Processo para produzir acido 5-aminosalicilico
BRPI0013750B8 (pt) intermediários para a produção de derivados de ácido naftiridina-3-carboxílico
ES2167975T3 (es) Procedimiento para la preparacion de acido shikimico y sus derivados.
ECSP034713A (es) Sales de adicion de acido malico de terbinafina
HN2001000152A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
CR7672A (es) Metodo microbiologico para la produccion de 11- alfa- hidroxiesteroides 7- alfa sustituidos
ES2184150T3 (es) Uso de derivados de los acidos 7-(1-aminometil-2-oxa-7-aza-biciclo(3.3.0)oct-7il)-quinoloncarboxilico y -naftiridoncarboxilico para el tratamiento de infecciones causadas por helicobacter pylori y de las afecciones gastroduodenales asociadas con ellas.
DK1940772T3 (da) Ny fremgangsmåde til fremstilling af kvaternære syre- og ammoniumsalte
BRPI0406626A (pt) Método para fazer um arranjo de formulações para tratar descontinuidades mucosais, produto, formulação para tratar descontinuidades mucosais, kit, dispositivo para tratar descontinuidades mucosais, sistema, e, composição esfoliante
CR7389A (es) SALES ESTABLES DEL ACIDO o- ACETILSALICILICO CON AMINOACIDOS BASICOS II
CR7118A (es) Nuevos derivados de acido sulfonico
HN1999000141A (es) Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
PY0112457A (es) Usos de acido bisfosfonico 1-amino-3-(n,n=dimethylamino)-propilydene-1,1
CU20070266A7 (es) Complejo de principio activo estable de sales del ácido o-acetilsalicílico con aminoácidos básicos y glicina